Key result
Compound 21 rapidly increases cardiac p-Akt ~3-fold alongside activation of adipose signaling pathways.
Why the study?
The mechanisms underlying angiotensin II type 2 receptor-induced facilitation of insulin sensitivity are not completely understood.
Does acute intravenous administration of the AT2 receptor agonist Compound 21 stimulate the phosphorylation of Akt and ERK1/2 in mouse heart and white adipose tissue in vivo?
Does acute intravenous administration of the AT2 receptor agonist Compound 21 stimulate the phosphorylation of Akt and ERK1/2 in mouse heart and white adipose tissue in vivo?
Demonstrates for the first time in vivo that acute pharmacological activation of the AT2 receptor with Compound 21 stimulates Akt and ERK1/2 signaling in cardiac and adipose tissue independently of insulin receptor phosphorylation.
Answers are grounded in this paper and cite their sources.
AT2 agonism activates cardiac and adipose Akt/ERK in mice; leaves open human therapeutic translation.
The angiotensin II type 2 (AT2) receptor has a role in promoting insulin sensitivity. However, the mechanisms underlying the AT2 receptor-induced facilitation of insulin are still not completely understood. Therefore, we investigated whether acute in vivo administration of AT2 receptor agonist compound 21 (C21) could activate insulin signaling molecules in insulin-target tissues. We report that, in male C57BL/6 mice, an acute (5 min, 0.25 mg/kg; i.v.) injection of C21 induces the phosphorylation of Akt and ERK1/2 at activating residues (Ser473 and Thr202/Tyr204, respectively) in both epididymal white adipose tissue (WAT) and heart tissue. In WAT, the extent of phosphorylation (p) of Akt and ERK1/2 induced by C21 was approximately 65% of the level detected after a bolus injection of a dose of insulin known to induce maximal activation of the insulin receptor (IR). In the heart, C21 stimulated p-Akt to a lesser extent than in WAT and stimulated p-ERK1/2 to similar levels to those attained by insulin administration. C21 did not modify p-IR levels in either tissue. We conclude that in vivo injection of the AT2 receptor agonist C21 activates Akt and ERK1/2 through a mechanism that does not involve the IR, indicating the participation of these enzymes in AT2R-mediated signaling.
No takes yet. Share an insight, caveat, or question.
Quiroga et al. (2023) studied AT2 receptor-mediated insulin signaling in heart and adipose tissue. Compound 21 (C21) vs. Vehicle (saline) and bolus insulin injection was evaluated on Phosphorylation of Akt (Ser473) and ERK1/2 (Thr202/Tyr204) in epididymal white adipose tissue and heart tissue (p=<0.05). Compound 21 increased heart p-Akt 2.5-3-fold and p-ERK1/2 1.8-fold over baseline, and stimulated white adipose tissue p-Akt to ~65% of maximal insulin levels within 5 minutes.
Synapse has enriched 10 related papers. Consider them for comparative context: